Vimarsana
Biggest News Aggregation in the World

Severity Triage Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Severity Triage Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Severity Triage Test Today - Breaking & Trending Today

SQI Diagnostics Inc. Announces Grant of Stock Options - Vimarsana News

SQI Diagnostics Inc. Announces Grant of Stock Options

/PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and...

SQI Diagnostics Submits RALI-Dx; IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization - Vimarsana News

SQI Diagnostics Submits RALI-Dx; IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

with Confirmed COVID-19 Illness TORONTO, April 1, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that it has submitted its fully completed clinical and analytical data package to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of its RALI-Dx ™ IL-6 Severity Triage Test. The submission was completed on March 31, 2021. The FDA wi...

SQI Diagnostics Receives $2.3 Million in Funds from Shareholder Exercise of Securities - Vimarsana News

SQI Diagnostics Receives $2.3 Million in Funds from Shareholder Exercise of Securities

Share this article Company Continues to Improve Gross Cash Position to Execute Business Plan TORONTO, March 8, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that 9,775,972 common share purchase warrants (the Warrants") and 1,500,000 stock options (the "Options") have been exercised at exercise prices between $0.09 and $0.30 per common shares since January 1, 20...

SQI Diagnostics Reports First Quarter 2021 Results - Vimarsana News

SQI Diagnostics Reports First Quarter 2021 Results

/PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid...

SQI Diagnostics Announces New Corporate Website - Vimarsana News

SQI Diagnostics Announces New Corporate Website

SQI Diagnostics Announces New Corporate Website News provided by Share this article New Website Provides Essential Information on Company's Strategic Initiative TORONTO, Feb. 18, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSX-V: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today is proud to announce the launch of its newly redesigned website at https://www.sqidiagnostics.com. The revamped site features a streamlined, mode...